Correlation Between Oric Pharmaceuticals and Design Therapeutics
Can any of the company-specific risk be diversified away by investing in both Oric Pharmaceuticals and Design Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oric Pharmaceuticals and Design Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oric Pharmaceuticals and Design Therapeutics, you can compare the effects of market volatilities on Oric Pharmaceuticals and Design Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oric Pharmaceuticals with a short position of Design Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oric Pharmaceuticals and Design Therapeutics.
Diversification Opportunities for Oric Pharmaceuticals and Design Therapeutics
-0.01 | Correlation Coefficient |
Good diversification
The 3 months correlation between Oric and Design is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding Oric Pharmaceuticals and Design Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Design Therapeutics and Oric Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oric Pharmaceuticals are associated (or correlated) with Design Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Design Therapeutics has no effect on the direction of Oric Pharmaceuticals i.e., Oric Pharmaceuticals and Design Therapeutics go up and down completely randomly.
Pair Corralation between Oric Pharmaceuticals and Design Therapeutics
Given the investment horizon of 90 days Oric Pharmaceuticals is expected to under-perform the Design Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Oric Pharmaceuticals is 1.45 times less risky than Design Therapeutics. The stock trades about -0.02 of its potential returns per unit of risk. The Design Therapeutics is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 566.00 in Design Therapeutics on September 23, 2024 and sell it today you would earn a total of 59.00 from holding Design Therapeutics or generate 10.42% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Oric Pharmaceuticals vs. Design Therapeutics
Performance |
Timeline |
Oric Pharmaceuticals |
Design Therapeutics |
Oric Pharmaceuticals and Design Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Oric Pharmaceuticals and Design Therapeutics
The main advantage of trading using opposite Oric Pharmaceuticals and Design Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oric Pharmaceuticals position performs unexpectedly, Design Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Design Therapeutics will offset losses from the drop in Design Therapeutics' long position.Oric Pharmaceuticals vs. Seer Inc | Oric Pharmaceuticals vs. Anebulo Pharmaceuticals | Oric Pharmaceuticals vs. Cullinan Oncology LLC | Oric Pharmaceuticals vs. C4 Therapeutics |
Design Therapeutics vs. Fate Therapeutics | Design Therapeutics vs. Sana Biotechnology | Design Therapeutics vs. Caribou Biosciences | Design Therapeutics vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing |